Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

InnovAge Holding Corp.

INNVNASDAQ
Healthcare
Medical - Care Facilities
$8.92
$0.00(0.00%)
U.S. Market opens in 1h 56m

InnovAge Holding Corp. Fundamental Analysis

InnovAge Holding Corp. (INNV) shows moderate financial fundamentals with a PE ratio of -293.34, profit margin of -0.45%, and ROE of -1.69%. The company generates $0.9B in annual revenue with strong year-over-year growth of 11.76%.

Key Strengths

Cash Position10.43%
PEG Ratio-5.87

Areas of Concern

ROE-1.69%
Operating Margin0.45%
We analyze INNV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 32.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
32.0/100

We analyze INNV's fundamental strength across five key dimensions:

Efficiency Score

Weak

INNV struggles to generate sufficient returns from assets.

ROA > 10%
-0.78%

Valuation Score

Excellent

INNV trades at attractive valuation levels.

PE < 25
-293.34
PEG Ratio < 2
-5.87

Growth Score

Moderate

INNV shows steady but slowing expansion.

Revenue Growth > 5%
11.76%
EPS Growth > 10%
-37.50%

Financial Health Score

Excellent

INNV maintains a strong and stable balance sheet.

Debt/Equity < 1
0.46
Current Ratio > 1
1.26

Profitability Score

Weak

INNV struggles to sustain strong margins.

ROE > 15%
-169.04%
Net Margin ≥ 15%
-0.45%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is INNV Expensive or Cheap?

P/E Ratio

INNV trades at -293.34 times earnings. This suggests potential undervaluation.

-293.34

PEG Ratio

When adjusting for growth, INNV's PEG of -5.87 indicates potential undervaluation.

-5.87

Price to Book

The market values InnovAge Holding Corp. at 4.71 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.71

EV/EBITDA

Enterprise value stands at 44.83 times EBITDA. This signals the market has high growth expectations.

44.83

How Well Does INNV Make Money?

Net Profit Margin

For every $100 in sales, InnovAge Holding Corp. keeps $-0.45 as profit after all expenses.

-0.45%

Operating Margin

Core operations generate 0.45 in profit for every $100 in revenue, before interest and taxes.

0.45%

ROE

Management delivers $-1.69 in profit for every $100 of shareholder equity.

-1.69%

ROA

InnovAge Holding Corp. generates $-0.78 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.78%

Following the Money - Real Cash Generation

Operating Cash Flow

InnovAge Holding Corp. generates limited operating cash flow of $56.67M, signaling weaker underlying cash strength.

$56.67M

Free Cash Flow

InnovAge Holding Corp. produces free cash flow of $45.99M, offering steady but limited capital for shareholder returns and expansion.

$45.99M

FCF Per Share

Each share generates $0.34 in free cash annually.

$0.34

FCF Yield

INNV converts 3.81% of its market value into free cash.

3.81%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-293.34

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-5.87

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.71

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.32

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.46

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.26

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.02

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

0.01

vs 25 benchmark

How INNV Stacks Against Its Sector Peers

MetricINNV ValueSector AveragePerformance
P/E Ratio-293.3429.45 Better (Cheaper)
ROE-1.69%779.00% Weak
Net Margin-0.45%-24936.00% (disorted) Weak
Debt/Equity0.460.26 Weak (High Leverage)
Current Ratio1.264.65 Neutral
ROA-0.78%-19344.00% (disorted) Weak

INNV outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews InnovAge Holding Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

48.07%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-213.48%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-26.23%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ